Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.69M Sell
103,707
-1,429
-1% -$34.2K 0.05% 171
2017
Q1
$2.58M Sell
105,136
-2,283
-2% -$55.9K 0.05% 181
2016
Q4
$2.66M Sell
107,419
-2,245
-2% -$49.9K 0.05% 171
2016
Q3
$2.3M Buy
109,664
+1,069
+1% +$22.9K 0.04% 180
2016
Q2
$2.29M Sell
108,595
-19,026
-15% -$355K 0.05% 185
2016
Q1
$2.41M Sell
127,621
-51,243
-29% -$976K 0.05% 165
2015
Q4
$3.79M Buy
178,864
+46,427
+35% +$947K 0.07% 126
2015
Q3
$2.23M Buy
132,437
+38,450
+41% +$757K 0.05% 176
2015
Q2
$1.67M Buy
93,987
+36,366
+63% +$630K 0.03% 227
2015
Q1
$1.01M Buy
57,621
+4,325
+8% +$79.2K 0.02% 299
2014
Q4
$991K Buy
53,296
+30,496
+134% +$501K 0.02% 300
2014
Q3
$338K Buy
22,800
+3,771
+20% +$59.5K 0.01% 494
2014
Q2
$289K Sell
19,029
-11,470
-38% -$170K 0.01% 525
2014
Q1
$514K Buy
30,499
+4,744
+18% +$77.5K 0.01% 393
2013
Q4
$441K Sell
25,755
-985
-4% -$17.1K 0.01% 349
2013
Q3
$406K Buy
26,740
+3,180
+13% +$45.5K 0.01% 361
2013
Q2
$327K Buy
+23,560
New +$311K 0.01% 332

Other funds holding NEOG

Geneva Advisors's NEOG Position: Q2 2017 in Review

Geneva Advisors reduced its Neogen (NEOG) stake by 1.4% in Q2 2017, selling an estimated $34.2K and leaving 103,707 shares worth $2.69M. The position accounts for 0.05% of the portfolio, ranked #171.

Geneva Advisors first reported a position in NEOG in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.79M in Q4 2015. 206 funds tracked by Wall St. Rank hold NEOG as of Q2 2017.

  • Geneva Advisors held 103,707 shares of Neogen worth $2.69M as of Q2 2017.
  • Geneva Advisors sold 1,429 Neogen shares in Q2 2017, an estimated $34.2K.
  • Neogen made up 0.05% of Geneva Advisors's portfolio in Q2 2017, its #171 holding.
  • Geneva Advisors first reported a position in Neogen in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Neogen position peaked at $3.79M in Q4 2015.
  • 206 funds tracked by Wall St. Rank held Neogen as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.